Assertion: actinium | /r/CapableOf | plan a phase 2 trial
Facets:
value: for actimab-mds
type: TRANSITIVE-OBJECT
value: as a conditioning regimen
type: MANNER
Source sentences:
text: Actinium is planning a Phase 2 trial for Actimab-MDS, our third CD33 program, as a conditioning regimen prior to a bone marrow transplant for patients with MDS that have a p53 genetic mutation.
text: Actinium is also planning a Phase 2 trial for Actimab-MDS, our third CD33 program candidate, as a conditioning regimen prior to a bone marrow transplant for patients with MDS that have a p53 genetic mutation.